New Delhi, Aug. 6 -- The Indian pharmaceutical sector has been "excluded" from the immediate US tariff imposition, as generic medicines are "important" for affordable healthcare in the United States, said Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, on Wednesday.

This comes after US President Donlad trump imposed an additional 25 per cent tariff on India over the continued purchase of Russian oil.

Jain, says, "The recent Executive Order by the US Administration excludes the pharmaceutical sector from immediate tariff imposition. The sector is being reviewed under the Section 232 investigation. Generic medicines are important for affordable healthcare in the US and typically operate on razor-thin margins. Ensu...